Company / Shares Outstanding
Arcus Biosciences, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
92.2M
FY2025
5-year range
65.1M / 92.2M
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
#107 of 212
Health Care
What the data says
At 92200000.00, Arcus Biosciences, Inc.'s shares outstanding ranks #106 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 863983.00 in FY2016 to 92200000.00 in FY2025.
Based on SEC 10-K filings.
92200000.00 in FY2025 with a 5-year CAGR of +15.0%.
Increased from 72900000.00 to 92200000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- +15.0%
- 10-Year CAGR
- -
Sector benchmark
#106 of 212 in Health CareTop 50% of 212This company 92.2M Sector average 306.7M
▼
-69.9% below sector average
Key checks
Key Insights
- Arcus Biosciences, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 22.1% year-over-year.
- Ranks #107 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 92.2M | +22.1% |
| FY2024 | 75.5M | +3.6% |
| FY2023 | 72.9M | +3.0% |
| FY2022 | 70.8M | +8.7% |
| FY2021 | 65.1M | +41.8% |
| FY2020 | 45.9M | +3.1% |
| FY2019 | 44.5M | +988.7% |
| FY2018 | 4.1M | +123.8% |
| FY2017 | 1.8M | +111.6% |
| FY2016 | 864.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026